ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7815
0.01%
Brent Oil
82.585
0.00%
Bitcoin
61,093.77
0.49%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. BioPharmX Corporation (BPMX)

  7. BioPharmX Corporation (BPMX) Noticias

BPMX

BioPharmX (BPMX)

BioPharmX Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:BPMX
FechaHoraFuenteTítuloSímboloCompañía
29/05/202005:04Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
28/05/202016:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
22/05/202016:17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
19/05/202015:41GlobeNewswire Inc.Timber Pharmaceuticals Announces Investor Conference CallAMEX:BPMXBioPharmX Corporation
15/05/202015:05PR Newswire (US)BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020AMEX:BPMXBioPharmX Corporation
13/05/202015:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
13/05/202015:05PR Newswire (US)BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingAMEX:BPMXBioPharmX Corporation
08/05/202008:00PR Newswire (US)BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsAMEX:BPMXBioPharmX Corporation
27/04/202015:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BPMXBioPharmX Corporation
27/04/202015:05PR Newswire (US)BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...AMEX:BPMXBioPharmX Corporation
06/04/202015:30PR Newswire (US)Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials GrantAMEX:BPMXBioPharmX Corporation
01/04/202015:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
01/04/202005:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
30/03/202005:17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:BPMXBioPharmX Corporation
25/03/202015:15PR Newswire (US)BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain TradingAMEX:BPMXBioPharmX Corporation
23/03/202015:24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/02/202005:03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:BPMXBioPharmX Corporation
13/02/202015:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
30/01/202015:30Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BPMXBioPharmX Corporation
30/01/202015:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
28/01/202015:30PR Newswire (US)BioPharmX And Timber Pharmaceuticals Announce Entry into Merger AgreementAMEX:BPMXBioPharmX Corporation
10/12/201915:51Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
10/12/201915:05PR Newswire (US)BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate UpdateAMEX:BPMXBioPharmX Corporation
20/09/201915:05PR Newswire (US)BioPharmX Receives Notice of Compliance Deadline Extension from NYSE AmericanAMEX:BPMXBioPharmX Corporation
09/09/201907:15PR Newswire (US)BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate UpdateAMEX:BPMXBioPharmX Corporation
18/07/201916:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
16/07/201915:15PR Newswire (US)BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating OfficerAMEX:BPMXBioPharmX Corporation
25/06/201906:30PR Newswire (US)BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular RosaceaAMEX:BPMXBioPharmX Corporation
11/06/201915:10PR Newswire (US)BioPharmX Reports Fiscal First Quarter 2020 Financial ResultsAMEX:BPMXBioPharmX Corporation
22/05/201915:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
 Showing the most relevant articles for your search:AMEX:BPMX

Su Consulta Reciente

NYSE
NKE
Nike
COIN
SOLUSD
Solana
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
ADDYY
Adidas (QX)
PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
FX
EURMXN
Euro vs MXN
CCOM
US30
US 30
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
FX
USDMXN
US Dollar vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados